Results 261 to 270 of about 2,040,864 (360)

Nanozymes in Reactive Oxygen Species‐Dependent Diseases: From Design and Preclinical Studies to Clinical Translation Prospects

open access: yesSmall Structures, EarlyView.
Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou   +8 more
wiley   +1 more source

Autonomous Artificial Molecular Motors and Pumps

open access: yesChemSystemsChem, EarlyView.
Autonomous energy consumption is the only way to introduce molecular motors into more sophisticated, larger systems, capable of life‐like behavior. We reviewed a selection of the most recent advances in the field molecular motors focusing on those capable of performing continuous and autonomous motion under constant experimental conditions, that is ...
Chiara Taticchi   +2 more
wiley   +1 more source

Evolution of macromolecular crystallography beamlines at the Swiss Light Source and SwissFEL

open access: yesJournal of Synchrotron Radiation, EarlyView.
This review examines two decades of continuous development in macromolecular crystallography beamlines at the Swiss Light Source, along with recent contributions from SwissFEL, in the broader context of the evolution of macromolecular crystallography at synchrotron and X‐ray free‐electron laser facilities.This review highlights the development and ...
Meitian Wang
wiley   +1 more source

Allosteric Enzymes

open access: bronze, 2016
B. Nagel, H. Dellweg, L. M. Gierasch
openalex   +2 more sources

Luteinizing hormone receptor knockout mouse: What has it taught us?

open access: yesAndrology, EarlyView.
Abstract Luteinizing hormone (LH), along with its agonist choriongonadotropin (hCG) in humans, is the key hormone responsible for the tropic regulation of the gonadal function. LH and hCG act through their cognate receptor, the luteinizing hormone/choriongonadotropin receptor (LHCGR; more appropriately LHR in rodents lacking CG), located in the testis ...
Ilpo T. Huhtaniemi
wiley   +1 more source

Exploring Aspartate Transcarbamoylase: A Promising Broad-Spectrum Target for Drug Development. [PDF]

open access: yesChembiochem
Chen S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy